Then I decided on $GDRX . This is a drug platform on which Americans can obtain medicines more cheaply. In view of the US administration's efforts to reduce drug prices, I think this is a promising opportunity for the future. Incidentally, one of the first partners to market their products via the platform is the very popular $NOVO B (-2.42%)

A small addition: the title is not yet tradable in Germany.